//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
The Peter Doherty Institute for Infection and Immunity is a joint-venture between The University of Melbourne and The Royal Melbourne Hospital. Research includes #HIV, #hepatitis, #malaria, #influenza #COVID19 & more. www.doherty.edu.au
Doherty Institute









Loading...
Next-generation flu vaccine delivers a stronger immune response to the A(H3N2) influenza strain in a new clinical trial, outperforming traditional egg- and cell-grown vaccines and highlighting the potential for improved seasonal protection. https://bit.ly/4uTCExz
Most people labelled “penicillin allergic” aren’t allergic. This World Allergy Week, Melb led trial highlights new model to safely rule it out through bedside testing in hospitals. ✅ Faster decisions ✅ Right antibiotics ✅ Better patient outcomes https://bit.ly/4fV6eiu
Congratulations Prof Laura Mackay and Prof Katherine Kedzierska, two newly elected Fellows to the Australian Academy of Science in recognition of their contributions to immunology and infectious diseases research. https://bit.ly/4a3mwll
On Saturday the first case of high pathogenicity avian influenza (HPAI) H5N1 was confirmed in Australia. What does this mean for our wildlife population? Origin, transmission and prevention measures explained by experts here 🔗 https://bit.ly/4eCSZAq
A landmark international clinical trial (SNAP Trial) has identified the optimal antibiotics for golden staph bloodstream infections, a breakthrough that is set to reshape treatment for the life-threatening condition. https://bit.ly/44eY8Kg
Discover our 2025 Impact Report, highlighting key achievements across the Doherty Institute's work in research, public health and education. Explore our digital 2025 Impact Report 🔗 https://bit.ly/3SMs5Ph
16h
Hantavirus has been in the news overseas, but what does it mean for Australia? Scientists at the Doherty Institute explain how the virus spreads, the symptoms it can cause, how testing works in Australia, and why the risk remains low. https://bit.ly/4uEIWl2
What to expect from the 2026 flu season - Experts share the latest case data and information on 2026 vaccine program. https://www.doherty.edu.au/articles/what-to-expect-from-the-2026-flu-season/
Parts of Australia are currently experiencing outbreaks of diphtheria, a vaccine-preventable bacterial illness. What causes diphtheria? What are the symptoms? How does it spread? Get answers to some of the most common questions about diphtheria. https://bit.ly/4ahSJFE
A current Ebola virus disease outbreak overseas has been declared a public health emergency of international concern by the WHO. Doherty Institute scientists unpack the key facts, from transmission and symptoms to laboratory testing and Australia’s risk. https://bit.ly/4dJ0buv
1d
1d
5d
1mo
6d
1mo
1mo
25d
29d
Doherty Institute
Doherty Institute
Doherty Institute
Doherty Institute
Doherty Institute
Doherty Institute
Doherty Institute
Doherty Institute
Doherty Institute
Doherty Institute
Our Impact Report captures a snapshot of what we achieved in 2025, showcasing the breadth and depth of our work in research, public health and education.
bit.ly
Explore our work in research, public health and education at the Doherty Institute.
www.doherty.edu.au
Impact Report 2025
The first case of H5N1 bird flu in Australia has been confirmed. What does this mean? - Doherty Institute
Melbourne researchers have led the world’s largest study confirming most patients labelled allergic to penicillin are not truly allergic.
bit.ly
World Allergy Week: Global study unlocks new way to rule out penicillin allergy
Hantavirus: Your questions answered - Doherty Institute
Explore our work in research, public health and education at the Doherty Institute.
www.doherty.edu.au
Internationally recognised for their contributions to immunology and infectious diseases research, University of Melbourne immunologists Professor Laura Mackay and Professor Katherine Kedzierska from the Doherty Institute have been elected as Fellows of...
www.doherty.edu.au
Explore our work in research, public health and education at the Doherty Institute.
www.doherty.edu.au
Doherty Institute scientists elected to the Australian Academy of Science - Doherty Institute
Recombinant flu vaccine shows stronger immune response in clinical trial - Doherty Institute
Doherty Institute experts answer common questions about diphtheria, covering symptoms, risks, and prevention for Australians.
bit.ly
A landmark international clinical trial has identified the optimal antibiotics for golden staph bloodstream infections, a breakthrough that is set to reshape treatment for the life-threatening condition.
Diphtheria: Your questions answered - Doherty Institute
Global clinical trial reveals safest, most effective antibiotics for golden staph bloodstream infections
www.doherty.edu.au
Explore our work in research, public health and education at the Doherty Institute.
www.doherty.edu.au
Ebola virus explained: Risks, symptoms and testing in Victoria  - Doherty Institute
Reported influenza cases so far in 2026 have halved compared to the same period in 2025, however last year was an unpredictable flu season. As we prepare for the start of winter, the most effective way to reduce the impact of respiratory infections is t...
www.doherty.edu.au
What to expect from the 2026 flu season - Doherty Institute